Metin Caner Çakır
Research Subjects
Research Interests
Metin Caner Çakır has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Sibel Ozden
İstanbul Üniversitesi, Eczacılık Fakültesi, Farmasötik Toksikoloji Anabilim Dalı
3 shared publications - Gamze Sarı1 shared publication
- Muberra Ozcan
Istanbul Universty
1 shared publication - Neslihan Elif Mutlu1 shared publication
- Zeynep Ciftci
İSTANBUL ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ ENSTİTÜSÜ
1 shared publication - Zeynep Rana Guler
Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Istanbul University, Istanbul, Turkey; Institute of Graduate Studies in Health Sciences, Istanbul University, Istanbul, Turkey
1 shared publication
Latest Publications
- 10 October 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 219
Curcumin attenuates beauvericin-induced global DNA methylation alterations in liver and colon cells
- 10 October 2026
- Published by Elsevier in Food and Chemical Toxicology
- Vol. 219
Curcumin attenuates beauvericin-induced global DNA methylation alterations in liver and colon cells
- 1 April 2026
- Published by Veterinary Journal of Ankara University in Ankara Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 73 (2) , 127-136
In vitro and in silico insights into moniliformin induced global DNA methylation in liver cells
Moniliformin (MON) is a mycotoxin that is not routinely monitored in foods; however, it is increasingly recognized as an emerging food safety concern. Although some clastogenic effects were observed, non-genotoxic mechanisms may also contribute to the toxic effects of MON. Therefore, this study aims to investigate the effects of global DNA methylation, the most studied non-genotoxic mechanism, on MON toxicity in human hepatocarcinoma (HepG2) cells. HepG2 cells were exposed to MON at 5, 10, and 50 M concentrations for 24 hours. Global DNA methylation levels and gene expression of DNMT1, DNMT3A, DNMT3B, TET1, TET2, and TET3 were analyzed. Interactions among B-DNA, DNMT1, DNMT3A, DNMT3B, and MON were investigated using molecular docking. MTT cytotoxicity assay revealed that the IC50 value of MON in HepG2 cells was 253±8.41 M. MON at 10 and 50 μM resulted in at least a 2.18-fold increase (P<0.05) in global DNA methylation levels, accompanied by upregulated expression of DNMT1 and DNMT3A. Moreover, 5, 10, and 50 M of MON resulted in at least 2.37-fold (P<0.05) increase in TET1 genes. In contrast, TET2 expression was significantly downregulated by at least 37% (P<0.05) and 42% (P<0.05) at 10 and 50 M of MON. However, TET3 expression showed no significant change in any treatment group. MON formed hydrogen bonds with B-DNA, DNMT1, DNMT3A, and DNMT3B. However, the binding energy calculations indicate that the interactions are not biologically active. This study suggests that alterations in global DNA methylation might have a role in MON-induced toxicity.
- 1 April 2026
- Published by Veterinary Journal of Ankara University in Ankara Üniversitesi Veteriner Fakültesi Dergisi
- Vol. 73 (2) , 127-136
In vitro and in silico insights into moniliformin induced global DNA methylation in liver cells
Moniliformin (MON) is a mycotoxin that is not routinely monitored in foods; however, it is increasingly recognized as an emerging food safety concern. Although some clastogenic effects were observed, non-genotoxic mechanisms may also contribute to the toxic effects of MON. Therefore, this study aims to investigate the effects of global DNA methylation, the most studied non-genotoxic mechanism, on MON toxicity in human hepatocarcinoma (HepG2) cells. HepG2 cells were exposed to MON at 5, 10, and 50 M concentrations for 24 hours. Global DNA methylation levels and gene expression of DNMT1, DNMT3A, DNMT3B, TET1, TET2, and TET3 were analyzed. Interactions among B-DNA, DNMT1, DNMT3A, DNMT3B, and MON were investigated using molecular docking. MTT cytotoxicity assay revealed that the IC50 value of MON in HepG2 cells was 253±8.41 M. MON at 10 and 50 μM resulted in at least a 2.18-fold increase (P<0.05) in global DNA methylation levels, accompanied by upregulated expression of DNMT1 and DNMT3A. Moreover, 5, 10, and 50 M of MON resulted in at least 2.37-fold (P<0.05) increase in TET1 genes. In contrast, TET2 expression was significantly downregulated by at least 37% (P<0.05) and 42% (P<0.05) at 10 and 50 M of MON. However, TET3 expression showed no significant change in any treatment group. MON formed hydrogen bonds with B-DNA, DNMT1, DNMT3A, and DNMT3B. However, the binding energy calculations indicate that the interactions are not biologically active. This study suggests that alterations in global DNA methylation might have a role in MON-induced toxicity.
- Open Access
- 9 May 2025
- Published by Elsevier in Toxicology Reports
- Vol. 14, 102046
The role of global DNA methylation in citrinin induced toxicity: In vitro and in silico approach
- 9 May 2025
- Published by Elsevier in Toxicology Reports
- Vol. 14, 102046
Open AccessThe role of global DNA methylation in citrinin induced toxicity: In vitro and in silico approach